What are the causes of elevated Dehydroepiandrosterone (DHEA) levels in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated DHEA/DHEAS Levels

Elevated DHEA/DHEAS levels in adults require systematic evaluation for three primary pathological causes: non-classical congenital adrenal hyperplasia, polycystic ovary syndrome (PCOS), and androgen-secreting adrenal tumors, with the urgency of workup determined by the absolute DHEAS level and presence of virilization symptoms. 1, 2

Critical Thresholds for Urgency

  • DHEAS >6000 ng/mL (16.3 μmol/L) demands urgent evaluation for adrenocortical carcinoma with immediate adrenal CT imaging 2, 3
  • Age-specific thresholds requiring investigation: >3800 ng/mL for ages 20-29, >2700 ng/mL for ages 30-39 1, 3
  • Rapidly progressive virilization symptoms escalate urgency regardless of absolute DHEAS level 2, 3

Primary Pathological Causes

Adrenal Tumors (Most Urgent)

  • Androgen-secreting adrenocortical carcinomas present with virilization in approximately 60% of cases, including hirsutism, voice deepening, and oligomenorrhea/amenorrhea in women 2
  • Peak incidence occurs in the fourth to fifth decades with a female-to-male ratio of 1.5:1 2
  • Malignancy should be suspected when tumors are >4-5 cm, have irregular margins, are lipid-poor, fail to wash out on contrast-enhanced CT, or secrete multiple hormones 2
  • Adrenal tumors account for 17-30% of cases with abnormal DHEAS levels 4, 5

Non-Classical Congenital Adrenal Hyperplasia

  • Must be ruled out first, particularly when DHEAS exceeds age-specific thresholds 1, 2, 3
  • Accounts for 32% of cases with low DHEAS (due to overtreatment) but can present with elevated levels when untreated 5, 6
  • Characterized by hypertension with hypokalemia and virilization (11-beta-hydroxylase deficiency) or incomplete masculinization in males and primary amenorrhea in females (17-alpha-hydroxylase deficiency) 4

Polycystic Ovary Syndrome (Most Common in Reproductive-Age Women)

  • PCOS is the most common cause of elevated androgens in reproductive-age women 3
  • Pathogenesis involves accelerated pulsatile GnRH secretion, insulin resistance, and downstream metabolic dysregulation 1
  • Diagnosed using 2 of 3 criteria: androgen excess, ovulatory dysfunction, and polycystic ovaries on ultrasound 3

Other Adrenal Causes

  • Cushing's syndrome presents with rapid weight gain (central distribution), proximal muscle weakness, depression, and hyperglycemia 4
  • Adrenoleukodystrophy in males can cause very high DHEAS without tumor; measure very long-chain fatty acids in serum when suspected 4, 2
  • Primary adrenal insufficiency typically shows low DHEAS levels along with low cortisol and aldosterone 4

Associated Clinical Conditions

Metabolic and Cardiovascular

  • Arterial hypertension is present in 26% of patients with high DHEAS levels 5
  • Overweight/obesity occurs in 19% of cases with elevated DHEAS 5
  • Significant correlation exists between DHEAS levels and body mass index, systolic and diastolic blood pressure 5

Other Associations

  • Non-toxic goiter (17% of cases) 5
  • Alopecia (9% of cases) 5
  • Acromegaly (rare): presents with acral features, enlarging shoe/glove/hat size, headache, visual disturbances, and diabetes mellitus 4

Diagnostic Algorithm

Initial Clinical Assessment

  • Evaluate for hyperandrogenism signs: hirsutism, acne, menstrual irregularities, androgenetic alopecia, infertility, voice deepening, clitoromegaly 1, 2, 3
  • In prepubertal children: early-onset body odor, axillary/pubic hair, accelerated growth, advanced bone age, genital maturation 1
  • Document rapidity of symptom progression (rapid progression strongly suggests malignancy) 2

Essential Laboratory Panel

  • Free and total testosterone, DHEAS, androstenedione, LH, FSH 1, 2, 3
  • 17-hydroxyprogesterone to screen for non-classical congenital adrenal hyperplasia 2, 3
  • Morning ACTH and cortisol to distinguish adrenal from pituitary sources 2, 3
  • Sex hormone binding globulin, free androgen index 1, 3
  • Consider: prolactin, estrogen, progesterone, insulin, lipid levels, IGF-1 in selected cases 1, 2

Imaging Studies

  • Adrenal CT scan when 21-hydroxylase antibodies are negative, DHEAS >6000 ng/mL, or clinical suspicion for adrenal tumor exists 4, 2, 3
  • Transvaginal ultrasound to evaluate for polycystic ovaries and ovarian masses in females 1, 2, 3

Specialized Testing

  • 2-day dexamethasone suppression test to distinguish functional from neoplastic causes of hyperandrogenism 1
  • Measure very long-chain fatty acids in males to exclude adrenoleukodystrophy 4, 2
  • 21-hydroxylase antibody testing for autoimmune adrenal disease 4

Critical Pitfalls to Avoid

  • Do not delay imaging when rapidly progressive virilization symptoms are present, as this strongly suggests malignancy 2
  • Do not assume PCOS without ruling out non-classical congenital adrenal hyperplasia and adrenal tumors first 1, 2, 3
  • Remember that primary adrenal insufficiency causes low DHEAS, not high; hyponatremia is present in 90% of cases 4
  • In treated congenital adrenal hyperplasia patients, DHEAS may be overly suppressed, limiting its value for monitoring therapy adequacy 6

References

Guideline

Elevated DHEA Sulfate Levels: Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Elevated DHEA/DHEAS Levels: Diagnosis and Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation and Management of Elevated DHEA-Sulfate

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.